Form 8-K - Current report:
SEC Accession No. 0001641172-25-020033
Filing Date
2025-07-17
Accepted
2025-07-17 15:22:13
Documents
14
Period of Report
2025-07-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 42475
2 EX-99.1 ex99-1.htm EX-99.1 13627
3 GRAPHIC ex99-1_001.jpg GRAPHIC 6701
  Complete submission text file 0001641172-25-020033.txt   227742

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cqens-20250717.xsd EX-101.SCH 3008
5 XBRL LABEL FILE cqens-20250717_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE cqens-20250717_pre.xml EX-101.PRE 22353
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3236
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
CQENS Technologies Inc. (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55470 | Film No.: 251130377
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)